Bioinorganic Chemistry. Rosette M. Roat-MaloneЧитать онлайн книгу.
Rich
Sharon
Suzanne
PREFACE
In 2015, Kara Bren, Richard Eisenberg, and Harry Gray presented their thoughts about the beginnings of bioinorganic chemistry [1]. They credit Pauling and Coryell as the first researchers to realize the importance of the metal and the structure around the metal as the determining factor in hemoglobin's function. The conclusions of Pauling and Coryell, presented 80+ years ago in the Proceedings of the National Academy of Sciences, used a Guoy balance to determine hemoglobin's magnetic behavior. In two 1936 publications, they confirmed that the oxygenated and carbonmonoxygenated forms of hemoglobin were diamagnetic and discovered that the deoxygenated form was magnetic with four unpaired electrons per iron ion [2]. Quoting Bren, Eisenberg, and Gray: “the development of structure/function relationships has been a central theme of modern bioinorganic chemistry, with much attention paid to metal ion electronic structure.” Structure determines function in bioinorganic chemistry and happily we have many modern methods to determine these relationships for the one‐third of proteins that are metalloproteins.
When I first taught a bioionorganic course in the early 1990s, I used the 1984 book written by Robert Hay [3]. I thought those 200 pages told the whole story. Soon I moved on to the 1994 publication (411 pages) by Stephen Lippard and Jeremy Berg [4]. Now, if I were still teaching, I would be faced with 739 pages in the 2007 publication put together by Ivano Bertini, Harry Gray, Ed Stiefel, and Joan Valentine as editors with the help of 60+ contributors [5]. Our bioinorganic field has grown fantastically in the past 30 years, with ongoing discoveries, new and improved methods, and new bioinorganic subdisciplines – nanobioinorganic chemistry for one.
My philosophy for the third edition of Bioinorganic Chemistry: A Short Course remains the same as that for the first two. Introduce inorganic chemistry and biochemistry basics (Chapter 1), and then move on to several topics presented in some detail. My goal is not to cover the whole, enormous, bioinorganic chemistry spectrum but to focus on a small number of metalloproteins and metalloenzymes (Chapters 3 and 4). Bioinorganic chemists need experimental and analytical methods: computers, computing, where to find information online (Chapter 2); cryo‐electron microscopy (Chapter 3); and other microscopy methods (Chapter 5). New areas of interest for me – nanobioinorganic chemistry and nanomedicine – are the subject of Chapter 5. Chapter 6, Metals in Medicine, updates a major area of continuing interest to me – metal‐containing anticancer compounds – and looks at a number of metal‐affected disease states.
In this book, structure/function relationships are emphasized for all metalloproteins and metalloenzymes with visualizations made possible using PyMOL and ChemDraw software, specifically the PyMOL Molecular Graphics System, Version 2.1.1, https://pymol.org and ChemDraw Prime 16.0.1.4 http://www.perkinelmer.com/category/chemdraw. I rely on up‐to‐date primary sources for all subject areas and anticipate readers will do the same. Science moves forward very quickly in bioinorganic chemistry and the way to keep up is to follow the current scientific literature.
Everyone interested in bioinorganic chemistry should be aware of the very extensive and helpful glossary of bioinorganic terminology published by the International Union of Pure and Applied Chemistry (IUPAC) available at https://old.iupac.org/publications/pac/1997/pdf/6906x1251.pdf.
What should we think or do about scientific ethics? A large number of scientists signed on to commentary on the subject of genome editing in Nature magazine in March 2019. The comment “Adopt a moratorium on heritable genome editing” appeared in the Comment section of Nature 567: 165–168. The comment's first sentence specifically states that changing heritable DNA in sperm, eggs, or embryos to make genetically modified children should undergo a global moratorium. Ethical questions about heritable genome editing are addressed in Section and in a question at the end of Chapter 1. All scientists should carry out their work in an ethical manner although the exact meaning of the term “ethical manner” is not always clear. We know not to falsify data or steal another's work. How we behave when discoveries make it possible to cure disease (good?) or change the genome of a future generation (bad?) are much thornier questions.
What should we think or do about errors? Errors creep in. Websites contain errors. Scientific publications contain errors – sometimes corrected, sometimes not. When learning a new subject and head scratching over an un‐understandable statement, label, or answer to a question, think about the possibility of an error. Protein data bank (PDB) accession numbers that identify molecules that have had their structures determined by X‐ray crystallography or nuclear magnetic resonance spectroscopy are a good example. Numbers and/or letters get transposed. The PDB code 1A3N will bring up data for the structure of deoxy human hemoglobin if you put that code in the search box at https://www.rcsb.org. Put in 1N3A and you will get data for human 8‐oxoguanine glycosylase. Some letters and numbers are unclear. The letter “O” is used instead of the number “0”. Or the letter “I” instead of the number “1.” There are errors in this book. I hope you will find them and report them to me at [email protected].
What should we think or do about et al.? Scientific papers often have numerous co‐authors. Normal practice for writing the reference after the third author is to add the Latin phrase “et al.” meaning “and others.” For a publication with six authors, who should be listed and who should be et al.? My practice has been to find the paper's corresponding author assuming that person would respond to a question about the research. Sometimes I know who the person heading the research is – head of laboratory, prominent scientist – and I include that person. This practice may leave out the person(s) who actually conducted the research. I don't think that is a fair practice but I don't have a solution. If you do let me know.
The cover illustration shows the active site of the nitrite reductase enzyme discussed in Section 4.4.3.2 and is illustrated further in Figure 4.26.
The text is accompanied by a website with address:
www.wiley.com/go/Roat‐Malone_Bioinorganic Chemistry
ROSETTE M. ROAT-MALONE
Washington College
REFERENCES
1 1. Bren, K.L., Eisenberg, R., Gray, H.B. (2015) Discovery of the magnetic behavior of hemoglobin: a beginning of bioinorganic chemistry Proc. Natl. Acad. Sci. U S A. 112(43): 13123–13127. doi: 10.1073/pnas.1515704112
2 2. (a) Pauling, L. and Coryell, C.D. (1936). The magnetic properties and structure of the hemochromogens and related substances. Proc. Natl. Acad. Sci. USA 22 (3): 159–163.(b) Pauling, L. and Coryell, C.D. (1936). The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc. Natl. Acad. Sci. USA 22 (4): 210–216.
3 3. Hay, R.W. (1984). Bio‐inorganic Chemistry. Sydney Australia: Halstead Press.
4 4. Lippard, S.J. and